JPS6037116B2 - 2―置換オキサゾロピリジン - Google Patents

2―置換オキサゾロピリジン

Info

Publication number
JPS6037116B2
JPS6037116B2 JP51089756A JP8975676A JPS6037116B2 JP S6037116 B2 JPS6037116 B2 JP S6037116B2 JP 51089756 A JP51089756 A JP 51089756A JP 8975676 A JP8975676 A JP 8975676A JP S6037116 B2 JPS6037116 B2 JP S6037116B2
Authority
JP
Japan
Prior art keywords
formula
lower alkyl
formulas
hydrogen
pyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP51089756A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5217495A (en
Inventor
ピー.ジエンセン ノーマン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JPS5217495A publication Critical patent/JPS5217495A/ja
Publication of JPS6037116B2 publication Critical patent/JPS6037116B2/ja
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/57Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/68Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings containing halogen
    • C07C63/72Polycyclic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP51089756A 1975-07-29 1976-07-29 2―置換オキサゾロピリジン Expired JPS6037116B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/600,169 US4011326A (en) 1975-07-29 1975-07-29 2-Substituted oxazolo[4,5-b]pyridine anti-inflammatory agents
US600169 1977-07-29

Publications (2)

Publication Number Publication Date
JPS5217495A JPS5217495A (en) 1977-02-09
JPS6037116B2 true JPS6037116B2 (ja) 1985-08-24

Family

ID=24402575

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51089756A Expired JPS6037116B2 (ja) 1975-07-29 1976-07-29 2―置換オキサゾロピリジン

Country Status (14)

Country Link
US (1) US4011326A (enExample)
JP (1) JPS6037116B2 (enExample)
AU (1) AU505159B2 (enExample)
BE (1) BE844577A (enExample)
CH (1) CH603661A5 (enExample)
DE (1) DE2633905A1 (enExample)
DK (1) DK320276A (enExample)
ES (1) ES450245A1 (enExample)
FR (1) FR2319354A1 (enExample)
GB (1) GB1497985A (enExample)
HU (1) HU172167B (enExample)
NL (1) NL7607794A (enExample)
SE (1) SE431545B (enExample)
ZA (1) ZA764527B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH085368Y2 (ja) * 1987-03-05 1996-02-14 日産自動車株式会社 内燃機関のコネクティングロッド
PT937075E (pt) * 1996-11-11 2004-05-31 Altana Pharma Ag Novas imidazo- e oxazolo-piridinas como inibidores da fosfodiesterese
ATE327753T1 (de) 2001-05-15 2006-06-15 Hoffmann La Roche Carbonsäure-substituierte oxazol-derivate zur verwendung als ppar-alpha und -gamma aktivatoren zur behandlung von diabetes
JP4202250B2 (ja) 2001-07-25 2008-12-24 バイオマリン ファーマシューティカル インコーポレイテッド 血液脳関門輸送を調節するための組成物および方法
RU2295520C2 (ru) * 2002-07-03 2007-03-20 Ф.Хоффманн-Ля Рош Аг ПРОИЗВОДНЫЕ ОКСАЗОЛА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ СЕНСИБИЛИЗАТОРОВ ИНСУЛИНА, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ АКТИВИРУЮЩИМ ДЕЙСТВИЕМ В ОТНОШЕНИИ PRARα И/ИЛИ PRARγ
EP1537091B1 (en) * 2002-08-30 2010-10-06 F. Hoffmann-La Roche AG Novel 2-arylthiazole compounds as pparalpha and ppargamma agonists
JP4286782B2 (ja) * 2002-09-12 2009-07-01 エフ.ホフマン−ラ ロシュ アーゲー 糖尿病の治療に有用な、pparアゴニストとしてのn−置換−1h−インドール−5−プロピオン酸化合物
RU2315767C2 (ru) * 2002-11-25 2008-01-27 Ф.Хоффманн-Ля Рош Аг Индолилпроизводные, способ их получения, фармацевтическая композиция, способ лечения и/или профилактики заболеваний
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
CN101594878A (zh) 2006-09-18 2009-12-02 雷普特药品公司 通过给予受体相关蛋白(rap)-缀合物对肝病症的治疗
DK3395372T3 (da) 2009-02-20 2022-04-19 Enhanx Biopharm Inc System til afgivelse af glutathion-baseret medikament
CN110075069A (zh) 2009-05-06 2019-08-02 实验室护肤股份有限公司 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其应用
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3935195A (en) * 1969-04-28 1976-01-27 Sterling Drug Inc. 4,4'-Stilbenebis-pyridooxazoles and related optical brighteners and polymeric compositions brightened thereby
FR2148362A1 (en) * 1971-08-11 1973-03-23 Ferlux 2-amino-(4,5-b)-oxazolopyridine cpds - with analgesic,anti-inflammato anticonvulsant,muscle relaxant and diuretic activity
AR208500A1 (es) * 1972-06-14 1977-02-15 Merck & Co Inc Procedimiento para la preparacion de derivados de oxazolo(4,5-b)-piridinas

Also Published As

Publication number Publication date
CH603661A5 (enExample) 1978-08-31
US4011326A (en) 1977-03-08
SE7608037L (sv) 1977-01-30
DE2633905A1 (de) 1977-02-17
ES450245A1 (es) 1979-05-16
NL7607794A (nl) 1977-02-01
SE431545B (sv) 1984-02-13
AU505159B2 (en) 1979-11-08
HU172167B (hu) 1978-06-28
JPS5217495A (en) 1977-02-09
DK320276A (da) 1977-01-30
FR2319354B1 (enExample) 1979-07-20
GB1497985A (en) 1978-01-12
BE844577A (fr) 1977-01-28
AU1605276A (en) 1978-01-26
ZA764527B (en) 1978-03-29
FR2319354A1 (fr) 1977-02-25

Similar Documents

Publication Publication Date Title
US4490371A (en) N,N-Disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkylamides
JPS6037116B2 (ja) 2―置換オキサゾロピリジン
LU85635A1 (fr) Nouveaux derives de la vinyl-6 furo-(3,4-c)-pyridine,leur preparation et compositions pharmaceutiques a base de ces composes
JPS63295556A (ja) 多環複素誘導体、その製法および人・動物医薬
AU2002331145B2 (en) Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
EP0082665B1 (en) Phenol esters
AU2002331145A1 (en) Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
JPH01294670A (ja) 2−(ピペラジニル)−2−オキソエチレン−置換フラボノイド誘導体、その製法およびそれを含有する医薬組成物
US4294847A (en) 8-Aminoalkyl-4-alkylisopsoralens
JPH0251914B2 (enExample)
JPS63196573A (ja) キナゾリン酢酸誘導体
JPS58109452A (ja) 抗炎症剤としてのヒドロキシベルジルアミノベンゼン
JPH0559117B2 (enExample)
JPS6045199B2 (ja) 新規なイミダゾベンゾオキサジン及びそれらを含む製薬組成物
JPH05125052A (ja) 新規環状アミノフエニル酢酸誘導体、その製造法及びそれらを有効成分とする免疫応答の修飾剤
DE2431292A1 (de) Neue carbazol-derivate
JPH02247185A (ja) 新規安息香酸誘導体及びその製造方法
JPS6353984B2 (enExample)
Bowen et al. The Synthesis and Nitration of 2, 6-and 2, 7-Dimethylquinoline and of 2, 5, 8-Trimethylquinoline
DD208798A5 (de) Verfahren zur herstellung von phenol-derivate
JPS6110587A (ja) 1−アザキサントン−3−カルボン酸誘導体およびその製造法
JPS6051465B2 (ja) 3−メチル−3−〔4−(1−オキソ−2−イソインドリニル)フェニル〕ピルビン酸エステル類
JPH0386866A (ja) 新規環状アントラニル酸カルボン酸誘導体及びその製造法
US4666909A (en) Bisbenzothiazine, bisbenzodiazine and bisquinoline pharmaceutical compositions and use
JPH03115289A (ja) 新規安息香酸誘導体、その製造方法及びその用途